Differential Diagnosis Of Pyogenic Granuloma: Distinguishing It From Melanoma And Squamous Cell Carcinoma
Published on: November 15, 2025
Differential Diagnosis of Pyogenic Granuloma Distinguishing it from melanoma and squamous cell carcinoma featured image
  • Article author photo

    Sowmya Tallam

    Bachelor of Science - BS, Biomedical Sciences Honours, Keele University

Overview

Pyogenic Granuloma (PG), also known as granuloma pyogenicum, is a benign vascular tumour commonly found in tissues such as the skin and mucosal membranes.¹ Typically, PG occurs in adults aged 20–50 years.² It is often alarming due to its striking appearance — a solitary, bright red, highly vascularised mass.³ PGs show rapid exophytic growth (growing outwards beyond the surface) and are most frequently located within the oral cavity,¹ though they can also appear on the hands, face, or near the fingernails.

Although non-cancerous, PGs can closely mimic serious skin cancers such as melanoma and squamous cell carcinoma (SCC).⁴ Not only that, but they may also still cause pain, bleeding, and poor wound healing. The mortality rate in affected individuals is reported to be three times higher than in the general population.

Causes

PG has no single cause but may be influenced by several contributing factors. Despite its name, pyogenic (“pus-producing”) is a misnomer. PG is not infectious and is not caused by bacteria or viruses.⁵

The most common trigger is minor trauma or irritation. Cuts, scratches, insect bites, or friction from rings or footwear can provoke excessive tissue repair, forming a vascular mass as the body overreacts to injury.⁶⁻⁷

Hormonal factors also play a role, particularly during pregnancy, giving rise to the so-called “pregnancy tumour”. This lesion typically forms in the mouth or on the gums due to increased oestrogen and progesterone levels.⁸

Certain medications can also induce PG-like lesions by altering blood vessel growth. These include retinoids, oral contraceptives, and some HIV drugs such as indinavir.⁹ Regardless of the cause, PG represents an overgrowth of small blood vessels, forming a smooth, red bump that bleeds easily — a benign vascular proliferation rather than a malignancy.

Why is it confused with skin cancer?

PG can easily be mistaken for malignant lesions, particularly melanoma and SCC.

The presentation varies: some patients develop one or two slowly growing ulcers, while others notice the sudden appearance of multiple rapidly enlarging nodules.² The fast growth rate — over days or weeks — may suggest a nodular melanoma. Another factor contributing to confusion is that PGs are highly vascular, bleeding readily with the slightest contact.¹⁰ This bleeding, also seen in melanoma and SCC, raises clinical suspicion of malignancy.

While melanomas are usually dark brown or black, and SCCs often appear as red, scaly or crusted plaques, PGs can share these colour features. Their bright red or occasionally darker pigmentation often contributes to diagnostic uncertainty.

Melanoma

Melanoma is a potentially life-threatening cancer of melanocytes, the pigment-producing cells of the skin.¹¹ It may affect anyone but is more common in older adults, fair-skinned individuals, and those with a family history or numerous moles. However, darker-skinned individuals can also develop melanoma, typically on sun-protected areas such as the soles or palms.¹²

Early detection is essential. Clinicians often apply the ABCDE rule for diagnosis:¹³

  • (A) Asymmetry: irregular shape or structure
  • (B) Border irregularity: uneven or notched margins (scored 0–8)
  • (C) Colour variation: differing shades (white, red, brown, dark brown, blue-green, black)
  • (D) Diameter: greater than 6 mm
  • (E) Evolving: changes in size, shape, or colour over time

Dermoscopic analysis allows dermatologists to compute a total dermoscopic score (TDS):¹⁴⁻¹⁶

  • TDS < 4.75 = benign
  • 4.75–5.45 = suspicious
  • 5.45 = likely malignant melanoma

Squamous cell carcinoma 

SCC is the second most common skin cancer, developing from squamous cells in the middle and outer skin layers.¹⁷ Chronic sun exposure and tanning beds are major risk factors, though SCC can also arise from scars or chronic wounds, particularly in immunocompromised individuals.¹⁸

Clinically, SCC presents as a firm, scaly red nodule or crusted patch that can be mistaken for PG. Areas most affected include the face, lips, ears, scalp, and backs of the hands.¹⁷⁻¹⁹ Early recognition and treatment are crucial to prevent deeper invasion or metastasis.

Differential diagnosis 

At early stages, distinguishing PG from melanoma and SCC can be difficult. Clinicians use a combination of patient history, physical examination, dermatoscopy, and biopsy.

  • Patient history: Questions include how long the lesion has been present and how quickly it has grown. PG tends to grow faster than melanoma or SCC. Other factors include recent trauma, pregnancy, or sun exposure, as all raise lesion risk²⁰
  • Physical examination: The doctor assesses lesion shape, texture, and size. They also note location and possible trauma or UV exposure. PGs bleed also easily on contact²¹
  • Dermatoscopy: This magnified skin examination can distinguish PG’s lobular vascular pattern from the irregular colour and asymmetry typical of melanoma or the scaly patches of SCC²²
  • Biopsy: If malignancy is suspected, tissue sampling confirms the diagnosis. A benign histology indicates PG, while atypical or malignant cells confirm melanoma or SCC

Treatments and outcomes

  • PG: Although harmless, PGs are typically removed because they bleed easily. Treatment options include laser therapy, surgical excision, or cryotherapy (freezing).²³ Recurrence is uncommon once the lesion is completely removed
  • Melanoma: Early detection is crucial, as melanoma can spread rapidly. Treatment usually involves surgical excision, sometimes combined with lymph node biopsy or imaging. Long-term monitoring is essential to detect recurrence or new lesions²⁴,²⁵
  • SCC: SCC is generally treated with surgical excision, although chemotherapy, topical creams, or radiation may also be used. An example is 5-fluorouracil (5-FU) cream.²⁶ Early detection often allows a complete cure.²⁷ Ongoing skin surveillance helps prevent future cancers

FAQs

Is PG contagious?

No. It is not bacterial, fungal, or viral.

What causes a PG?

Injury or trauma, pregnancy-related hormonal changes, or certain medications.

Can a PG turn into cancer?

No. It is benign and does not increase cancer risk, though it can mimic malignant lesions.

Why does a PG bleed so much?

It consists of numerous fragile blood vessels, making it prone to bleeding from minimal friction.

Will it go away on its own?

Occasionally. Pregnancy-related PGs may regress as hormones stabilise, but treatment is generally recommended to prevent recurrence.

Summary

It is vital to distinguish PG from melanoma and SCC to ensure accurate diagnosis. PGs typically appear as red, smooth, fast-growing lesions that bleed easily yet remain benign. In contrast, melanoma and SCC are malignant and may spread quickly if untreated. Microscopic examination and biopsy are essential for confirmation. Although PG is harmless, vigilance is key to ruling out cancer.

References

  1. Sarwal P, Lapumnuaypol K. Pyogenic Granuloma [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556077/
  2. Understanding pyoderma gangrenosum [Internet]. Available from: https://www.wwic.wales/uploads/files/documents/Publications/published%20understanding-pyoderma-gangrenosum.pdf
  3. Pe'er J. Conjunctival stromal tumours. W.B. Saunders; 2009. p. 150–7. Available from: https://www.sciencedirect.com/science/article/abs/pii/B9781416031673500334
  4. Pyogenic Granuloma - EyeWiki [Internet]. eyewiki.org. Available from: https://eyewiki.org/Pyogenic_Granuloma
  5. Sabiston CB, Grigsby WR. The Microbiology of Dentalpyogenic Infections. CRC Critical Reviews in Clinical Laboratory Sciences. 1977 Jan 1;8(3):213–40.
  6. Jafarzadeh H, Sanatkhani M, Mohtasham N. Oral pyogenic granuloma: a review. Journal of Oral Science [Internet]. 2006 [cited 2019 Aug 2];48(4):167–75. Available from: https://www.jstage.jst.go.jp/article/josnusd/48/4/48_4_167/_pdf/-char/en
  7. Kamal R, Dahiya P, Puri A. Oral pyogenic granuloma: Various concepts of etiopathogenesis. Journal of Oral and Maxillofacial Pathology [Internet]. 2012;16(1):79. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303528/
  8. Patil K, VG Mahima, K Lahari. Extragingival pyogenic granuloma. Indian Journal of Dental Research. 2006 Jan 1;17(4):199–9.
  9. Katta R, Bickle K, Hwang L. Pyogenic granuloma arising in port-wine stain during pregnancy. British Journal of Dermatology [Internet]. 2001 Mar 1 [cited 2025 Apr 10];144(3):644–5. Available from: https://academic.oup.com/bjd/article-abstract/144/3/644/6690929?login=false
  10. Skin in HIV [Internet]. Google Books. 2015 [cited 2025 Apr 10]. Available from: https://books.google.co.uk/books?hl=en&lr=&id=jq45CQAAQBAJ&oi=fnd&pg=PP1&dq=Pyogenic+Granuloma+-+PG+is+full+of+tiny+blood+vessels+and+bleeds+with+the+slightest+touch.+HIV+medications+such+as+indinavir.&ots=tUNAdG4jPV&sig=aR5z7PbxTMtUhQjf-mIsBbx8Ivw#v=onepage&q&f=false
  11. Wang JY, Wang EB, Swetter SM. What Is Melanoma? JAMA [Internet]. 2023 Mar 3;329(11). Available from: https://jamanetwork.com/journals/jama/article-abstract/2802151
  12. Sudha S. Study Of Cutaneous Disorders In Geriatric Age Group. 1931574 [Internet]. 2025 [cited 2025 Apr 10]; Available from: http://20.193.157.4:9595/handle/123456789/2436
  13. Duarte AF, Sousa-Pinto B, Azevedo LF, Barros AM, Puig S, Malvehy J, et al. Clinical ABCDE rule for early melanoma detection. European Journal of Dermatology. 2021 Dec;31(6):771–8.
  14. Kasmi R, Mokrani K. Classification of malignant melanoma and benign skin lesions: implementation of automatic ABCD rule. IET Image Processing. 2016 Jun;10(6):448–55.
  15. Menzies SW, Moloney FJ, Byth K, Avramidis M, Argenziano G, Zalaudek I, et al. Dermoscopic evaluation of nodular melanoma. JAMA dermatology [Internet]. 2013 Jun 1;149(6):699–709. Available from: https://pubmed.ncbi.nlm.nih.gov/23553375/
  16. Cabrera R, Recule F. Unusual Clinical Presentations of Malignant Melanoma: A Review of Clinical and Histologic Features with Special Emphasis on Dermatoscopic Findings. American Journal of Clinical Dermatology. 2018 Oct 30;19(S1):15–23.
  17. BERNSTEIN SC, LIM KK, BRODLAND DG, HEIDELBERG KA. The Many Faces of Squamous Cell Carcinoma. Dermatologic Surgery. 1996 Mar;22(3):243–54.
  18. Bottomley MJ, Thomson J, Harwood C, Leigh I. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2019 Apr 24;20(8):2009.
  19. Aslam AM, Patel AN. Facial cutaneous squamous cell carcinoma. BMJ. 2016 Mar 31;i1513.
  20. Alessandrini A, Bruni F, Starace M, Piraccini BM. Periungual Pyogenic Granuloma: The Importance of the Medical History. Skin Appendage Disorders [Internet]. 2016 May 1 [cited 2021 Mar 21];1(4):175–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908441/
  21. Kaleeny JD, Janis JE. Pyogenic Granuloma Diagnosis and Management: A Practical Review. Plastic and Reconstructive Surgery - Global Open [Internet]. 2024 Sep [cited 2024 Nov 26];12(9):e6160. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11398770/#sec6
  22. Proquest.com. 2025 [cited 2025 Apr 10]. Available from: https://www.proquest.com/docview/2848393837?fromopenview=true&pq-origsite=gscholar
  23. Lee J, Sinno H, Tahiri Y, Gilardino MS. Treatment options for cutaneous pyogenic granulomas: A review. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2011 Sep;64(9):1216–20.
  24. Jones EL, Jones TS, Pearlman NW, Gao D, Stovall R, Gajdos C, et al. Long-term Follow-up and Survival of Patients Following a Recurrence of Melanoma After a Negative Sentinel Lymph Node Biopsy Result. JAMA Surgery. 2013 May 1;148(5):456.
  25. Papageorgiou C, Apalla Z, Manoli SM, Lallas K, Vakirlis E, Lallas A. Melanoma: Staging and Follow-Up. Dermatology Practical & Conceptual. 2021 Jul 28;11(S1):2021162S.
  26. Lin CP, Nour Kibbi, Tarek Bandali, Hirotsu K, Aasi SZ. 5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment response. Journal of the American Academy of Dermatology [Internet]. 2024 Nov 1 [cited 2025 Feb 23]; Available from: https://www.jaad.org/article/S0190-9622(24)03114-1/abstract?utm_source
  27. J.J. Bonerandi, C. Beauvillain, L. Caquant, Chassagne JF, V. Chaussade, P. Clavère, et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. 2011 Dec 1;25:1–51.
Share

Sowmya Tallam

Bachelor of Science - BS, Biomedical Sciences Honours, Keele University

arrow-right